(Q33806770)

29 July 2017

1 reference

title

Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens (English)

1 reference

29 July 2017

1 reference

Gaston RS

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

Transplantation Proceedings

29 July 2017

published in

1 reference

29 July 2017

volume

31

1 reference

29 July 2017

issue

8A

1 reference

29 July 2017

page(s)

17S-22S

1 reference

The mechanism of action of cyclosporin A and FK506

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Control of p70 s6 kinase by kinase activity of FRAP in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Long-term in vivo effects of rapamycin on humoral and cellular immune responses in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Rapamycin inhibits vascular smooth muscle cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

SDZ RAD, a new rapamycin derivative: synergism with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin)

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Emerging strategies for the clinical application of rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

A prospective randomized trial of FK506-based immunosuppression after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900843-X

7 January 2021

10.1016/S0041-1345(99)00843-X

Identifiers

DOI

1 reference

29 July 2017

1 reference